Medicaid expansion to reduce racial disparity in the incidence of early onset colorectal cancer.

Authors

null

Shafia Rahman

Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY

Shafia Rahman , Riya Jayesh Patel , Jianyou Liu , Ana Acuna-Villaorduna , Mimi Kim , Sanjay Goel

Organizations

Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, Jacobi Medical Center, Bronx, NY, Department of Epidemiology and Population Heath, Albert Einstein College of Medicine, New York, NY, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, Department of Epidemiology and Population Heath, Albert Einstein College of Medicine, Bronx, NY, Albert Einstein College of Medicine, The Bronx, NY

Research Funding

No funding received

Background: Early onset colorectal cancer (EO-CRC, age < 50 years) is an emerging public health crisis, especially in minorities. We evaluated and compared the effects of Medicaid expansion on the incidence of EO-CRC among Hispanics, Blacks, and Whites across the United States. Methods: The National Cancer Data Base was used to collect data on newly diagnosed cases of EO-CRC (40-49 years) among the three races, across all stages, from 2010-2017. Data for 21 expansion states (ES) that expanded Medicaid in 2014, and 16 non-expansion (NES) states was analyzed, excluding the states which expanded after 2014.The yearly state-wise population of all three races was collected from the U.S Census Bureau for 2010-17. A segmented Poisson regression model with generalized estimating equations was used for statistical analysis. Results: Annual incidence (AI) of EO-CRC pre and post expansion, in ES was 6/100,000 and 9/100,000 in Hispanics; 17/100,000 and 21/100,000 in Blacks and 14/100,000 and 18/100,000 for Whites. In NES the AI, pre and post 2014 was 8/100,000 and 10/100,000 among Hispanics, 19/100,00 and 24/100,000 among Blacks and 16/100,000 and 20/100,000 among Whites. Rate of change in AI of EO-CRC among Hispanics was 4.3% per year (2010-14), and 9.8% (2014-17) for ES states; and 6.4% (2010-14), and 1% (2014-17) in NES; among blacks was 3.8 % per year (2010-14), and 1.3% (2014-17) for ES states; and 1.6% (2010-14), and 3.2% (2014-17) in NES. Among Whites, increase in AI was 4.3% per year (2010-14), and 6.3% (2014-17) for ES states; and 4.0% (2010-14), and 5.7% (2014-17) in NES. ES showed greater change in incidence after expansion compared to pre-expansion in the incidence of EO-CRC as compared to NES (p=0.03) in Hispanics, however no significant difference was noted among Blacks (p=0.33) and Whites(p=0.94). Racial groups did significantly differ with respect to the degree of change in pre and post expansion (2014) rates of incidence of EO- CRC in the ES, however, in the NES, there were significant difference between the Hispanics and Whites (p=0.01), but not between Blacks versus Whites. Conclusions: Medicaid expansion reduces racial disparities in detection of EOCRC.

Comparison of yearly incidence rate of change by racial groups (Expansion year-2014).

HispanicsBlacksWhites
Before expansionAfter expansionBefore expansionAfter expansionBefore expansionAfter expansion
Non-expansion states6.4%1.0%1.6%3.2%4.0%5.7%
(2.2%, 10.7%)(-3.8%, 6.0%)(-0.7%, 3.9%)(-0.1%, 6.6%)(2.7%, 5.3%)(3.6%, 7.7%)
Expansion states4.3%9.8%3.8%1.3%4.3%6.3%
(0.7%, 8.0%)(5.2%, 14.7%)(-0.1%, 7.9%)(-2.5%, 5.3%)(2.1%, 6.6%)(4.5%, 8.0%)
p-value0.030.330.94

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Cancer Disparities

DOI

10.1200/JCO.2022.40.4_suppl.024

Abstract #

24

Poster Bd #

B2

Abstract Disclosures

Similar Abstracts

First Author: Shafia Rahman

Abstract

2022 ASCO Quality Care Symposium

Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings.

First Author: Jennifer C. Spencer

First Author: Michael Lyudmer

First Author: Alyssa Pereslete